<p>Device-based rhythm therapy has fundamentally evolved in recent years. Conventional implants consisting of a&#xa0;generator and transvenous leads have largely been optimized and are now characterized by miniaturization, extended battery life and magnetic resonance imaging (MRI) compatibility. To circumvent specific lead-related complications, novel technologies, such as leadless pacemakers and subcutaneous implantable cardioverter defibrillators (ICD) are gaining prominence. In the realm of physiological pacing methods conduction system pacing (CSP), particularly left bundle branch pacing (LBB pacing), is increasingly complementing traditional cardiac resynchronization therapy. Furthermore, innovative approaches such as artificial intelligence (AI)-assisted diagnostics, wearables and biological pacemakers offer promising prospects but require careful clinical evaluation.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Aktuelle Entwicklungen in der Device-basierten Rhythmustherapie

  • Tomas Madej,
  • Dieter Bimmel,
  • Asen Petrov,
  • Ali Taghizadeh-Waghefi,
  • Munira Maurer,
  • Alexander Siebel,
  • Michael Knaut

摘要

Device-based rhythm therapy has fundamentally evolved in recent years. Conventional implants consisting of a generator and transvenous leads have largely been optimized and are now characterized by miniaturization, extended battery life and magnetic resonance imaging (MRI) compatibility. To circumvent specific lead-related complications, novel technologies, such as leadless pacemakers and subcutaneous implantable cardioverter defibrillators (ICD) are gaining prominence. In the realm of physiological pacing methods conduction system pacing (CSP), particularly left bundle branch pacing (LBB pacing), is increasingly complementing traditional cardiac resynchronization therapy. Furthermore, innovative approaches such as artificial intelligence (AI)-assisted diagnostics, wearables and biological pacemakers offer promising prospects but require careful clinical evaluation.